{
 "PrintNo":"A4804","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2023-02-23T10:05:29.884366Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Consumer Affairs And Protection",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-01-03","Committee":"Consumer Affairs And Protection"}],
 "Actions":[
  {"Text":"REFERRED TO CONSUMER AFFAIRS AND PROTECTION","Date":"2023-02-23","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO CONSUMER AFFAIRS AND PROTECTION","Date":"2024-01-03","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":1248,"Name":"Robert Smullen","Short":"SMULLEN"}],
 "Title":"Relates to certain labelling requirements when substitute drug products are dispensed",
 "Summary":"Requires the brand name of a prescribed drug to be indicated on the label when substitute drug products are dispensed.",
 "LawSection":"Education Law","LawCode":"Amd ยง6816-a, Ed L",
 "ActClause":"AN ACT to amend the education law, in relation to certain requirements when substitute drug products are dispensed",
 "PreviousVersions":["A6054-2009","A3840-2011","A5447-2013","A4785-2015","A2761-2017","A4571-2019","A2258-2021"]
}